• Contact/
  • Home/

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • About
  • Team
  • Portfolio
  • Exit History
  • News

  • Advent Life Sciences
  • Advent Life Sciences

Page 12 of 25

 
<< Start < Prev 7 8 9 10 11 12 13 14 15 16Next >End >>
22.09.2015Artax Biopharma Funded to Clinically Develop Breakthrough Oral Therapies for Autoimmune Diseases

Press Release

21.09.2015Positive Topline Results Announced from Phase I/II Trial in Sanfilippo B Syndrome Patients Using uniQure’s Novel AAV5-Based Gene Therapy

Press Release

13.07.2015EDWARDS LIFESCIENCES ENTERS INTO AGREEMENT TO ACQUIRE CARDIAQ

Press Release

10.07.2015Success of Cellnovo’s IPO with €31.6 million raised on Euronext in Paris

Press Release

24.04.2015BIOCARTIS RAISES EUR 100 MILLION IN SUCCESSFUL INITIAL PUBLIC OFFERING

Press Release

06.03.2015Aura Biosciences Closes $21M Series B Financing

Press Release

04.03.2015 Macrolide Pharmaceuticals, Inc. Raises $22 Million in Series A Financing

Press Release

21.01.2015Versartis Announces Pricing of Follow - On Offering

Press Release

21.01.2015The American Hospital Association Exclusively Endorses Vestex® Active Barrier Apparel from Vestagen Technical Textiles, Inc.

Press Release

09.01.2015Versartis Initiates Global Phase 3 Study of VRS-317 in Children With Growth Hormone Deficiency

Press Release



  • Privacy Policy
  • Legal and Regulatory Matters

©2022 Advent Life Sciences